A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism

Cited by (335)

Items 101–200 of 335

1. Genetic Epidemiology of Parkinson's Disease
   Haydeh Payami, Sepideh Zareparsi · 1998 · Journal of Geriatric Psychiatry and Neurology
2. Potential Role of Fluoride in the Etiopathogenesis of Alzheimer’s Disease
   Marta Goschorska, Irena Baranowska‐Bosiacka, Izabela Gutowska, Emilia Metryka, Marta Skórka-Majewicz, Dariusz Chlubek · 2018 · International Journal of Molecular Sciences
3. Potential genetic markers of sporadic Alzheimerʼs dementia
   Retz, W., Thome, J., Durany, N., Harsányi, A., Retz-Junginger, P., Kornhuber, J., Riederer, P., Rösler, M. · 2001 · Psychiatric Genetics
4. Candidate Gene Association Studies in Sporadic Alzheimer’s Disease
   Onofre Combarros, Amaya Alvarez-Arcaya, Marisa Sánchez-Guerra, Jon Infante, José Berciano · 2002 · Dementia and Geriatric Cognitive Disorders
5. The genetics of Alzheimer's disease
   David Chaim Rubinsztein · 1997 · Progress in Neurobiology
6. Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease
   Sivaprakasam R. Saroja, Abhijeet Sharma, Patrick R. Hof, Ana C. Pereira · 2021 · Alzheimer s & Dementia
7. The diagnostic role of serum inflammatory and soluble proteins on dementia subtypes: Correlation with cognitive and functional decline
   Öztürk, Candan, Özge, Aynur, Yalın, Osman Özgür, Yılmaz, İ. Arda, Delialioglu, Nuran, Yıldız, Çilem, Tesdelen, Bahar, Kudiaki, Cigdem · 2007 · Behavioural Neurology
8. Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients
   Davide Seripa, Maria Giovanna Matera, Gloria Dal Forno, Carolina Gravina, Carlo Masullo, Antonio Daniele, Giuliano Gb. Binetti, Cristian Bonvicini, Rosanna Squitti, Mark T. Palermo et al. · 2004 · Neurobiology of Aging
9. α1‐Antichymotrypsin as a risk modifier for late‐onset Alzheimer's disease in Japanese apolipoprotein E ε4 allele carriers
   Aoi Yoshiiwa, Kouzin Kamino, H. Yamamoto, Toshiko Kobayashi, Masaki Imagawa, Yasuhiro Nonomura, Hiroshi Yoneda, Tatsuo Sakai, Yumiko Nishiwaki, N. Sato et al. · 1997 · Annals of Neurology
10. No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample
    Danielle Fallin, Amy Kundtz, Terrence Town, Ann C. Gauntlett, Ranjan Duara, William Barker, Fiona Crawford, MICHAEL J. MULLAN · 1997 · Neuroscience Letters
11. Genetic study of Apolipoprotein E gene, alpha‐1 antichymotrypsin gene in sporadic Parkinson disease
    Guomei Tang, Huijun Xie, Lin Xu, Yixin Hao, Dayu Lin, Daming Ren · 2002 · American Journal of Medical Genetics
12. Genetic Epidemiology of Alzheimer Disease
    Arjen J. C. Slooter, Cornelia M. van Duijn · 1997 · Epidemiologic Reviews
13. Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients
    Mikko O. Hiltunen, Arto Mannermaa, Seppo Helisalmi, Anne Maria Koivisto, Maarit Lehtovirta, Markku Ryynänen, Paavo J. Riekkinen, Hilkka S. Soininen · 1998 · Neuroscience Letters
14. Apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: finding of a positive association for a polymorphism in the TNFRSF6 gene
    Lars Feuk, Jonathan A. Prince, Gerome D. Breen, Tesfai Emahazion, Andrew D. Carothers, David St Clair, Anthony J. Brookes · 2000 · Human Genetics
15. Nature and nurture: Interaction and coaction
    Gerald E. McClearn · 2003 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
16. Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease
    Federico Licastro, Steve Pedrini, Marzia Govoni, Annalisa Pession, Cinzia Ferri, Giorgio Annoni, Valeria M. Casadei, Fabrizio Veglia, Stefano Bertolini, Luigi M.E. Grimaldi · 1999 · Neuroscience Letters
17. Association of alpha1-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis
    Ravi Mahadeva · 2001 · Thorax
18. Molecular Aspects of Inflammatory and Immune Responses in Alzheimer's Disease
    Raj N. Kalaria, M. Harshbarger-Kelly, David Cohen, Daniel R. Premkumar · 1996 · Neurobiology of Aging
19. Genetic variation in α1-antichymotrypsin and its association with Alzheimer’s disease
    Xiaoyan Wang, Steven Trent DeKosky, Erin Luedecking‐Zimmer, Mary Ganguli, M. Ilyas Kamboh · 2002 · Human Genetics
20. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations
    Fiona Crawford, Dani Fallin, Z. Suo, Laila I. Abdullah, Michael Gold, Ann C. Gauntlett, Ranjan Duara, MICHAEL J. MULLAN · 1998 · Neuroscience Letters
21. Brain immune responses cognitive decline and dementia: relationship with phenotype expression and genetic background
    Federico Licastro · 2003 · Mechanisms of Ageing and Development
22. Cerebral amyloid angiopathies
    Francisco Coria, I. Rubio · 1996 · Neuropathology and Applied Neurobiology
23. Association of α1‐antichymotrypsin polymorphism with cerebral amyloid angiopathy
    Masahito Yamada, Nobuyuki Sodeyama, Yoshinori Itoh, Naomi Suematsu, Eiichi Otomo, Masaaki Matsushita, Hidehiro Mizusawa · 1998 · Annals of Neurology
24. Lack of association of very low density lipoprotein receptor gene polymorphism with caucasian Alzheimer's disease
    Kaoru Okuizumi, Osamu Onodera, Hajime Tanaka, Shoji Tsuji, Koji Seki, Yoshio Namba, Kazuhiko Ikeda, Ann M. Saunders, Margaret Ann Pericak‐Vance, Allen D. Roses · 1996 · Annals of Neurology
25. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer’s disease
    Federico Licastro, Martina Chiappelli, Luigi M. E. Grimaldi, Kevin Morgan, Noor A Kalsheker, Elena Calabrese, Alistair Ritchie, Elisa Porcellini, Giuliana Salani, M. Franceschi et al. · 2004 · Neurobiology of Aging
26. Molecular Neurobiology of Alzheimer's Disease (Syndrome?)
    George S. Zubenko · 1997 · Harvard Review of Psychiatry
27. α-1-Antichymotrypsin gene polymorphism and susceptibility to multiple system atrophy (MSA)
    Yoshiko Furiya, Makito Hirano, Norio Kurumatani, T Nakamuro, Ryusuke Matsumura, Naonobu Futamura, Satoshi Ueno · 2005 · Molecular Brain Research
28. Genetic Risk Factors in Japanese Alzheimer’s Disease Patients: α1-ACT, VLDLR, and ApoE
    Hisashi Yamanaka, Kohei Kamimura, Hiroshi Tanahashi, Keikichi Takahashi, Takashi Asada, Takeshi Tabira · 1998 · Neurobiology of Aging
29. Biological Markers in Alzheimer Disease
    Judith A. Neugroschl, Kenneth L. Davis · 2002 · American Journal of Geriatric Psychiatry
30. Apolipoprotein E and α1‐antichymotrypsin polymorphism in Alzheimer's disease
    Benedetta Nacmias, Andrea Tedde, Stefania Latorraca, Silvia Piacentini, Laura Bracco, Luigi A. Amaducci, Sandro Sorbi, Biancamaria Guarnieri, Concetta Petruzzi, Luigi Ortenzi · 1996 · Annals of Neurology
31. Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population
    Kenji Isoe, Katsuya Urakami, Yong Ji, Yoshiki Adachi, Kenji Nakashima · 1996 · Acta Neurologica Scandinavica
32. Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications
    Joe Butchart, Clive Holmes · 2011 · CNS Neuroscience & Therapeutics
33. Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic review
    Huq, Aamira J., Fransquet, Peter, Laws, Simon M., Ryan, Joanne, Sebra, Robert, Masters, Colin L., Winship, Ingrid M., James, Paul A., Lacaze, Paul · 2019 · Alzheimer's & Dementia
34. APOE genetic associations with seizure development after severe traumatic brain injury
    Megan A. Miller, Yvette P. Conley, Joelle M. Scanlon, Dianxu Ren, M. Ilyas Kamboh, Christian Niyonkuru, Amy Kathleen Wagner · 2010 · Brain Injury
35. The essential role of inflammation and induced gene expression in the pathogenic pathway of Alzheimer s disease
    Huntington Potter · 1998 · Frontiers in bioscience
36. No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease
    William K. Scott, Larry H. Yamaoka, P. A. Locke, B.L. Rosi, Perry C. Gaskell, Ann M. Saunders, P. Michael Conneally, Gary W. Small, Lindsay A. Farrer, John H. Growdon et al. · 1997 · Genetic Epidemiology
37. Genetic risk factors in familial Alzheimer's disease
    Sandro Sorbi, Paolo Forleo, Andrea Tedde, Elena Cellini, Monica Ciantelli, Silvia Bagnoli, Benedetta Nacmias · 2001 · Mechanisms of Ageing and Development
38. Genetic risk factors of sporadic Alzheimer’s disease among Chinese in Taiwan
    Chaur‐Jong Hu, Shing‐Ming Sung, Hsing‐Cheng Liu, Wei-Chen Hsu, Long-Shyong Lee, Cheng-Chun Lee, Chang-Hai Tsai, Jan-Gowth Chang · 2000 · Journal of the Neurological Sciences
39. Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome
    Johannes Thome, Alessandra Baumer, Johannes Kornhuber, Michael Rösler, Peter Franz Riederer · 1995 · Journal of Neural Transmission - Parkinsons Disease and Dementia Section
40. Lack of Association Between Interleukin-1α Polymorphism and Alzheimer Disease or Vascular Dementia
    Yu‐Min Kuo, Pao‐Chi Liao, Chingju Lin, Chih-Wei J. Wu, Hsueh‐Meei Huang, Chih‐Chien Lin, Liang-Jen Chuo · 2003 · Alzheimer Disease & Associated Disorders
41. Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene‐related dementias: a morphological study
    Tammaryn Lashley, Janice L. Holton, Marcel M. Verbeek, Agueda A. Rostagno, M. Bojsen‐Møller, Guido David, Jack van Horssen, Hans Brændgaard, Gordon Terence Plant, Blas Frangione et al. · 2006 · Neuropathology and Applied Neurobiology
42. Genetic association between susceptibility to Parkinson's disease and α1-antichymotrypsin polymorphism
    Mitsutoshi Yamamoto, Ikuko Kondo, Norio Ogawa, Masato Asanuma, Yoshiaki Yamashita, Yoshikuni Mizuno · 1997 · Brain Research
43. Sporadic inclusion body myositis: the genetic contributions to the pathogenesis
    Qiang Gang, Conceição Bettencourt, Pedro Machado, Michael G. Hanna, Henry Houlden · 2014 · Orphanet Journal of Rare Diseases
44. Uses of Evolutionary Theory in the Human Genome Project
    Alan R. Templeton · 1999 · Annual Review of Ecology and Systematics
45. ?1-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease
    Taro Muramatsu, S. Matsushita, Hiroyuki Arai, H. Sasaki, Susumu Higuchi · 1996 · Journal of Neural Transmission
46. Apolipoprotein E, angiotensin-converting enzyme and α-1-antichymotrypsin genotypes are not associated with post-stroke dementia
    Ana Arpa, Teodoro del Ser, Guillermo Goda, Raquel Barba, Belén Bornstein · 2003 · Journal of the Neurological Sciences
47. The molecular genetics of Alzheimer's disease
    MICHAEL J. MULLAN, Fiona Crawford · 1994 · Molecular Neurobiology
48. Defining the molecular signatures of human right heart failure
    Jordan L. Williams, Omer Cavus, Eméfah C. Loccoh, Sara A. Adelman, John C. Daugherty, Sakima Ahmad Smith, Benjamin D. Canan, Paul M.L. Janssen, Sara N. Koenig, Crystal F. Kline et al. · 2018 · Life Sciences
49. Globular Glial Mixed Four Repeat Tau and TDP ‐43 Proteinopathy with Motor Neuron Disease and Frontotemporal Dementia
    Ryoko Takeuchi, Yasuko Toyoshima, Mari Tada, Hidetomo Tanaka, Hiroshi Shimizu, Atsushi Shiga, Takeshi Miura, Kenju Aoki, Akane Aikawa, Shin Ishizawa et al. · 2015 · Brain Pathology
50. Microsatellite polymorphism of the α 1 -antichymotrypsin gene locus associated with sporadic Alzheimer's disease
    Kevin Morgan, Linda Morgan, KAREN CARPENTER, James S Lowe, Letty Lam, Samantha Cave, John H. Xuereb, Claude M. Wischik, Charles R. Harrington, Noor A Kalsheker · 1996 · Human Genetics
51. Apolipoprotein E and Intronic Polymorphism of Presenilin 1 and Alpha-1-Antichymotrypsin in Alzheimer’s Disease and Vascular Dementia
    T. Rodriguez Martin, Anna Maria Calella, S. Silva, Elettra Munna, Piergiorgio Modena, Roberto Chiesa, S. Terrevazzi, Rosa Maria Ruggieri, R. Palermo, Federico Piccoli et al. · 2000 · Dementia and Geriatric Cognitive Disorders
52. Effect of cytokines, dexamethazone and the A/T-signal peptide polymorphism on the expression of alpha1-antichymotrypsin in astrocytes: significance for Alzheimer's disease
    Lars N. G. Nilsson, Saumya Das, Huntington Potter · 2001 · Neurochemistry International
53. Lack of association of trinucleotide repeat polymorphisms in the very‐low‐density lipoprotein receptor gene with Alzhelner's disease
    Haeyong Chung Ba, Carol T. Roberts, Steven Mark Greenberg, George William Rebeck, Richard Christie Bs, Robert B. Wallace, Howard J. Jacob, Bradley T. Hyman · 1996 · Annals of Neurology
54. α 1 -Antichymotrypsin Gene ( SERPINA3 ) A/T Polymorphism as a Risk Factor for Aneurysmal Subarachnoid Hemorrhage
    Agnieszka Słowik, Anna Borratyńska, Wojciech Turaj, Joanna Pera, Tomasz Dziedzic, Denise A. Figlewicz, Marek Betlej, Tadeusz Krzyszkowski, Ryszard Adam Czepko, Andrzej Szczudlik · 2005 · Stroke
55. Polymorphism in the alpha1-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations
    Kevin Morgan, Federico Licastro, Louise A. Tilley, Alistair Ritchie, Linda Morgan, Steve Pedrini, Noor A Kalsheker · 2001 · Human Genetics
56. Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population
    Sapkota, Bishwa, Subramanian, Anuradha, Priamvada, Gargi, Finely, Hadley, Blackett, Piers R., Aston, Christopher E., Sanghera, Dharambir K. · 2015 · Journal of Diabetes and its Complications
57. Polygenic resilience scores capture protective genetic effects for Alzheimer’s disease
    Jiahui Hou, Jonathan Hess, Nicola J. Armstrong, Joshua C. Bis, Benjamin Grenier‐Boley, Ida Karlsson, Ganna Leonenko, Katya T. Numbers, Eleanor K. O’Brien, Alexey A. Shadrin et al. · 2022 · Translational Psychiatry
58. Inflammation in Alzheimer’s disease
    Michael Thomas Heneka · 2006 · Clinical Neuroscience Research
59. Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease
    Chang‐Seok Ki, Duk Lyul Na, Hye Jin Kim, Jong-Won Kim · 2001 · Neuroscience Letters
60. α-Antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population
    Mario Ezquerra, Rafael Blesa, Eduard Tolosa, Francisca Ballesta, Rafael Oliva · 1998 · Neuroscience Letters
61. Familial and Population‐Based Studies of Apolipoprotein E and Alzheimer's Diseasea
    MICHAEL J. MULLAN, Paul Scibelli, Ranjan Duara, Danielle Fallin, Michael Robert Gold, John A. Schinka, Jonathan B. Hoyne, Aaron R Osborne, Steven Sevush, Fiona Crawford · 1996 · Annals of the New York Academy of Sciences
62. Using game theory and decision decomposition to effectively discern and characterise bi-locus diseases
    Nassim Versbraegen, Aziz Fouché, Charlotte Nachtegael, Sofia Papadimitriou, Andrea M. Gazzo, Guillaume Smits, Tom Lenaerts · 2019 · Artificial Intelligence in Medicine
63. Apolipoprotein E polymorphism in various dementias in Taiwan Chinese population.
    H. M. Huang, Yu‐Min Kuo, Hsio‐Chung Ou, C.-C. Lin, Liang-Jen Chuo · 2002 · Journal of Neural Transmission
64. Effect of Genetic Risk Factors and Disease Progression on the Cerebrospinal Fluid Tau Levels in Alzheimer's Disease
    Hiroyuki Arai, Masanori Terajima, Masakazu Miura, Susumu Higuchi, Taro Muramatsu, Sachio Matsushita, Nobuo Machida, Takuma Nakagawa, Virginia M.-Y. Lee, John Q. Trojanowski et al. · 1997 · Journal of the American Geriatrics Society
65. Plasma α1-antichymotrypsin in Alzheimer’s disease; relationships with APOE genotypes
    Renato Scacchi, M. Ruggeri, Giuseppe Gambina, Maria Cristina Martini, G. Ferrari, Rosa Maria Corbo · 2001 · Neurobiology of Aging
66. Genetic Epidemiology of Alzheimer Disease
    Richard P Mayeux · 2006 · Alzheimer Disease & Associated Disorders
67. APOE Polymorphism in a Rural Older Population-Based Sample in India
    Bittianda Kuttapa Thelma, Ramesh C. Juyal, Hiroko Hayama Dodge, Rajesh S. Pandav, Vijay Chandra, Mary Ganguli · 2001 · Human Biology
68. α2-Macroglobulin polymorphism is not associated with AD or AD-type neuropathology in the Japanese
    Nobuyuki Sodeyama, Masahito Yamada, Yoshinori Itoh, Naomi Suematsu, Masato Matsushita, Eiichi Otomo, Hidehiro Mizusawa · 2000 · Neurology
69. T/G polymorphism at intron 9 of presenilin 1 gene is associated with, but not responsible for sporadic late-onset Alzheimer's disease in Japanese population
    Yumiko Nishiwaki, Kouzin Kamino, Aoi Yoshiiwa, Naoyuki Sato, Kyoko Tateishi, Masatoshi Takeda, Toshiko Kobayashi, Hideki Yamamoto, Yasuhiro Nonomura, Hiroshi Yoneda et al. · 1997 · Neuroscience Letters
70. Genetic association of two chromosome 14 genes (presenilin 1 and α1‐Antichymotrypsin) with Alzheimer's disease
    Xiaoyan Wang, Steven Trent DeKosky, Stephen R. Wisniewski, Christopher E. Aston, M. Ilyas Kamboh · 1998 · Annals of Neurology
71. Blood amyloid levels and risk of dementia in the Ginkgo Evaluation of Memory Study (GEMS): A longitudinal analysis
    Oscar L. López, Yue‐Fang Chang, Diane G. Ives, Beth Ellen Snitz, Annette L. Fitzpatrick, Michelle C. Carlson, Stephen R. Rapp, Jeffrey D. Williamson, Russell P. Tracy, Steven Trent DeKosky et al. · 2019 · Alzheimer s & Dementia
72. Genes and osteoporosis
    Struan F.A. Grant, Sandra M. Ralston · 1997 · Trends in Endocrinology and Metabolism
73. No association between the HLA-A2 allele and Alzheimer disease
    Gary W. Small, William K. Scott, Scott Komo, Larry H. Yamaoka, Lindsay A. Farrer, Sanford H. Auerbach, Ann M. Saunders, Allen D. Roses, Jonathan L. Haines, Margaret Ann Pericak‐Vance · 1999 · Neurogenetics
74. Alpha 1-antichymotrypsin interaction with A beta (1-42) does not inhibit fibril formation but attenuates the peptide toxicity.
    Michael Y. Aksenov, Marina V Aksenova, Carney Jm, David Allan Butterfield · 1996 · PubMed
75. Biological Markers for the Clinical Diagnosis of Alzheimer's Disease.
    Hiroyuki Arai · 1996 · The Tohoku Journal of Experimental Medicine
76. Apolipoprotein E ?4 allele distribution in Wernicke-Korsakoff syndrome with or without global intellectual deficits
    Taro Muramatsu, Masaru Kato, Toshifumi Matsui, Haruo Yoshimasu, Aihide Yoshino, Sachio Matsushita, Susumu Higuchi, H. Kashima · 1997 · Journal of Neural Transmission
77. α 1 -Antichymotrypsin Gene Polymorphism in Patients With Stroke
    Nicolás Vila, Vı́ctor Obach, Marián Revilla, Rafael Oliva, Ángel Chamorro · 2000 · Stroke
78. Apolipoprotein E Genotyping as a Diagnostic Adjunct for Alzheimer's Disease
    Allen D. Roses, Ann M. Saunders · 1997 · International Psychogeriatrics
79. D2 dopamine receptor polymorphism and brain regional glucose metabolism
    Ernest Pascal Noble, Louis A. Gottschalk, James H. Fallon, Terry L. Ritchie, Joseph C. Wu · 1997 · American Journal of Medical Genetics
80. Apolipoprotein E and Alpha-1-Antichymotrypsin Genotypes Do Not Predict Time to Psychosis in Alzheimer's Disease
    Robert A. Sweet, M. Ilyas Kamboh, Stephen R. Wisniewski, Oscar L. López, William Edward Klunk, Daniel Kaufer, Steven Trent DeKosky · 2002 · Journal of Geriatric Psychiatry and Neurology
81. Inclusion body myositis.
    M.J. Garlepp, Frank Louis Mastaglia · 1996 · Journal of Neurology Neurosurgery & Psychiatry
82. An IL-1α susceptibility polymorphism in Alzheimer’s disease
    Joseph Rogers · 2000 · Neurology
83. Modifier Genes and Oligogenic Disease
    Sarita Agarwal, Nikhil Moorchung · 2005 · Journal of Nippon Medical School
84. Bivariate genetic analysis of fasting insulin and glucose levels
    Harold Snieder, Dorret Irene Boomsma, Lorenz J.P. van Doornen, Michael Churton Neale · 1999 · Genetic Epidemiology
85. α 1 -Antichymotrypsin gene polymorphism and susceptibility to Parkinson’s disease
    Esteban Muñoz, Vı́ctor Obach, Rafael Oliva, M. J. Martí, Mario Ezquerra, Pau Pástor, F Ballesta, Eduardo Tolosa · 1999 · Neurology
86. Erbliche Ursachen und Risikofaktoren der Alzheimer-Krankheit
    Nicola T. Lautenschlager, Alexander Kurz, Ulrich Müller · 1999 · Der Nervenarzt
87. MOLECULAR GENETICS OF ALZHEIMER'S DISEASE With special emphasis on presenilin, amyloid beta precursor protein and apolipoprotein E genes
    Kuopion Yliopisto, Seppo Helisalmi · 1998
88. Physical morbidity in elderly psychiatric inpatients: prevalence and possible relations between the major mental disorders and physical illness
    Dimitrios Adamis, Chris Ball · 2000 · International Journal of Geriatric Psychiatry
89. Analysis of apolipoprotein E, α1-antichymotrypsin and presenilin-1 genes polymorphisms in dementia caused by normal pressure hydrocephalus in man
    Benedetta Nacmias, Andrea Tedde, Biancamaria Guarnieri, Concetta Petruzzi, Luigi Ortenzi, Antonio Serio, Luigi A. Amaducci, Sandro Sorbi · 1997 · Neuroscience Letters
90. Absence of Association of α1-Antichymotrypsin Polymorphisms with Alzheimer's Disease: A Report on Autopsy-Confirmed Cases
    S. Itabashi, H. Arai, T. Matsui, S. Matsushita, T. Muramatsu, S. Higuchi, J. Trojanowski, Hidetada Sasaki · 1998 · Experimental Neurology
91. Lexikon der Syndrome und Fehlbildungen
    Regine Witköwski, Otto Prokop, Eva Ullrich · 1999 · Springer eBooks
92. Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta
    Maruf Mohammad Akbor, Nobuyuki Kurosawa, Hiroki Nakayama, Ayumi Nakatani, Koji Tomobe, Yoichi Chiba, Masaki Ueno, Masashi Tanaka, Yasuyuki Nomura, Masaharu Isobe · 2021 · PLoS ONE
93. No association between α1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease
    Seppo Helisalmi, Arto Mannermaa, Maarit Lehtovirta, Markku Ryynänen, Paavo Johannes Riekkinen, Hilkka Soininen · 1997 · Neuroscience Letters
94. A Novel Presenilin 1 Mutation (Leu166Arg) Associated With Early-Onset Alzheimer Disease
    Mario Ezquerra, Cristóbal Carnero Pardo, Rafael Blesa, Rafael Oliva · 2000 · Archives of Neurology
95. No effect of the alpha 1-antichymotrypsin A allele in Alzheimer's disease
    Olivier Didierjean, Maria M. Martinez, Dominique Campion, Didier Hannequin, Bruno Dubois, Cosette Martin, Michèle Puel, Catherine Thomas-Antérion, Florence Pasquier, O Moreau et al. · 1997 · Journal of Neurology Neurosurgery & Psychiatry
96. α1-Antichymotrypsin interaction with Aβ(1–42) does not inhibit fibril formation but attenuates the peptide toxicity
    Michael Y. Aksenov, Marina V Aksenova, John M. Carney, David Allan Butterfield · 1996 · Neuroscience Letters
97. Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer’s Disease
    Ingrid H.C.H.M. Philippens, Jan A. M. Langermans · 2021 · Vaccines
98. 1-Antichymotrypsin Polymorphism: A Risk Factor for Hemorrhagic Stroke in Normotensive Subjects
    Vı́ctor Obach, M. Revilla, N. Vila, Axell Cervera, A. Chamorro · 2001 · Stroke
99. Allele frequencies of +874T→A single nucleotide polymorphism at the first intron of IFN-γ gene in Alzheimer’s disease patients
    Letizia Scola, Federico Licastro, Martina Chiappelli, Claudio Franceschi, Luigi Maria Edoardo Grimaldi, Antonio Crivello, Giuseppina Colonna‐Romano, Giuseppina Candore, Domenico Lio, Calogero Caruso · 2003 · Aging Clinical and Experimental Research
100. Distribution of plasma α1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls
     X Wang · 2002 · Neurobiology of Aging